Stephanie Stein
Research Subjects
Research Interests
Stephanie Stein has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Elisabeth Kulle
Division of Pediatric Endocrinology and Diabetes, Department of Children and Adolescent Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
1 shared publication - Ansgar Wilhelm Lohse
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication - Christian Casar
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication - Christoph Schramm
Department of Medicine I and Martin Zeitz Center for Rare Diseases, European Reference Network on Hepatological Diseases (ERN Rare-Liver), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication - Dakyung Lee
1st Department of Medicine, and
1 shared publication - Dorothee Schwinge
1st Department of Medicine, and
1 shared publication
Latest Publications
- Open Access
- 4 March 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (8)
Testosterone affects female CD4+ T cells in healthy individuals and autoimmune liver diseases
Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are autoimmune liver diseases with strong female predominance. They are caused by T cell–mediated injury of hepatic parenchymal cells, but the mechanisms underlying this sex bias are unknown. Here, we investigated whether testosterone contributes to T cell activation in women with PBC. Compared with sex- and age-matched healthy controls ( n = 23), cisgender (cis) women with PBC ( n = 24) demonstrated decreased testosterone serum levels and proinflammatory CD4 + T cell profile in peripheral blood. Testosterone suppressed the expression of TNF and IFN-γ by human CD4 + T cells in vitro. In trans men receiving gender-affirming hormone therapy (GAHT) ( n = 25), testosterone affected CD4 + T cell function by inhibiting Th1 and Th17 differentiation and by supporting the differentiation into regulatory Treg. Mechanistically, we provide evidence for a direct effect of testosterone on T cells using mice with T cell–specific deletion of the cytosolic androgen receptor. Supporting a role for testosterone in autoimmune liver disease, we observed an improved disease course and profound changes in T cell states in a trans man with AIH/primary sclerosing cholangitis (PSC) variant syndrome receiving GAHT. We here report a direct effect of testosterone on CD4 + T cells that may contribute to future personalized treatment strategies.
- 4 March 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (8)
Open AccessTestosterone affects female CD4+ T cells in healthy individuals and autoimmune liver diseases
Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are autoimmune liver diseases with strong female predominance. They are caused by T cell–mediated injury of hepatic parenchymal cells, but the mechanisms underlying this sex bias are unknown. Here, we investigated whether testosterone contributes to T cell activation in women with PBC. Compared with sex- and age-matched healthy controls ( n = 23), cisgender (cis) women with PBC ( n = 24) demonstrated decreased testosterone serum levels and proinflammatory CD4 + T cell profile in peripheral blood. Testosterone suppressed the expression of TNF and IFN-γ by human CD4 + T cells in vitro. In trans men receiving gender-affirming hormone therapy (GAHT) ( n = 25), testosterone affected CD4 + T cell function by inhibiting Th1 and Th17 differentiation and by supporting the differentiation into regulatory Treg. Mechanistically, we provide evidence for a direct effect of testosterone on T cells using mice with T cell–specific deletion of the cytosolic androgen receptor. Supporting a role for testosterone in autoimmune liver disease, we observed an improved disease course and profound changes in T cell states in a trans man with AIH/primary sclerosing cholangitis (PSC) variant syndrome receiving GAHT. We here report a direct effect of testosterone on CD4 + T cells that may contribute to future personalized treatment strategies.